BioPharma

December 21, 2016

Vitality Biopharma Receives DEA Approval for Cannabinoid Pharma Development Facility

As a component of this process, Vitality's preclinical studies for its proprietary prodrugs of CBD and THC were reviewed and approved by…

Read More